United States · FDA National Drug Code directory
Imatinib Mesylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42292-043_3ed7760b-0703-b47e-e063-6294a90a61f3
- Product NDC
- 42292-043
- Form
- TABLET, FILM COATED
- Composition / generic term
- imatinib
- Labeler
- Mylan Institutional Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170907
- Source listing expiry
- 20261231
Source-listed ingredients
- IMATINIB MESYLATE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 BLISTER PACK in 1 CARTON (42292-043-03) / 1 TABLET, FILM COATED in 1 BLISTER PACK (42292-043-01) · 42292-043-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →